CYP 0.00% 25.0¢ cynata therapeutics limited

Ann: Cynata to Increase Exposure in Japan, page-35

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 348 Posts.
    lightbulb Created with Sketch. 86
    2017 Market For Cell Therapy Manufacturing – Strategies for Pricing, Cost Control, Reimbursement, Distribution, & More


    https://www.aboutpharma.com/blog/20...cost-control-reimbursement-distribution-more/

    quote >>>

    This global strategic report provides detailed analysis of ten leading cell therapy companies worldwide, evaluating the strengths of each company, as well as identifying cell therapy products in development, manufacturing strategies, and partnerships.
    These companies include:
    • ReNeuron
    • Mesoblast Ltd.
    • Asterias Biotherapeutics
    • TiGenix NV
    • Cellectis
    • Cynata Therapeutics
    • Cytori Therapeutics
    • Astellas Pharma (and Subsidiary Ocata Therapeutics)
    • Gamida Cell Ltd.
    • Pluristem Therapeutics
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.